| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
13,629 |
13,473 |
$2.10M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,986 |
3,906 |
$1.28M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,721 |
5,642 |
$1.27M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
6,671 |
6,532 |
$778K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,636 |
3,616 |
$351K |
| 80053 |
Comprehensive metabolic panel |
8,889 |
8,642 |
$154K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
832 |
343 |
$146K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
496 |
493 |
$142K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
191 |
190 |
$106K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,810 |
2,679 |
$69K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
10,531 |
10,237 |
$69K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
133 |
93 |
$63K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,210 |
1,594 |
$44K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
547 |
541 |
$40K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
725 |
721 |
$34K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
12 |
12 |
$26K |
| 71046 |
Radiologic examination, chest; 2 views |
1,131 |
1,128 |
$18K |
| 43248 |
|
38 |
38 |
$14K |
| D9999 |
Unspecified adjunctive procedure, by report |
12 |
12 |
$11K |
| 71045 |
Radiologic examination, chest; single view |
910 |
890 |
$9K |
| 83735 |
|
1,266 |
1,231 |
$8K |
| 70450 |
Computed tomography, head or brain; without contrast material |
153 |
150 |
$7K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,102 |
1,085 |
$6K |
| C1889 |
Implantable/insertable device, not otherwise classified |
14 |
13 |
$6K |
| 84100 |
|
1,164 |
1,131 |
$5K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
24 |
24 |
$4K |
| 81001 |
|
1,423 |
1,400 |
$4K |
| 81025 |
|
531 |
526 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
272 |
269 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
68 |
67 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
1,043 |
1,009 |
$3K |
| 87807 |
|
224 |
219 |
$3K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
27 |
27 |
$3K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
67 |
64 |
$2K |
| 81003 |
|
731 |
728 |
$2K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
17 |
17 |
$1K |
| 84484 |
|
128 |
115 |
$1K |
| 87081 |
|
204 |
201 |
$1K |
| 83605 |
|
122 |
118 |
$1K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
13 |
13 |
$1K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
12 |
12 |
$1K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
15 |
15 |
$894.06 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
814 |
761 |
$694.27 |
| 83690 |
|
109 |
106 |
$605.80 |
| 82550 |
|
102 |
91 |
$573.84 |
| 80305 |
|
52 |
50 |
$554.43 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,056 |
988 |
$366.48 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
12 |
12 |
$142.60 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
842 |
819 |
$131.11 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
13 |
13 |
$85.89 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
17 |
12 |
$32.87 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
440 |
424 |
$27.66 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
245 |
242 |
$10.02 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
27 |
25 |
$9.59 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,944 |
1,877 |
$7.39 |
| G0500 |
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) |
13 |
12 |
$6.96 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
146 |
134 |
$5.06 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
415 |
395 |
$4.47 |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
13 |
12 |
$2.24 |
| J1940 |
Injection, furosemide, up to 20 mg |
40 |
39 |
$0.60 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
13 |
12 |
$0.59 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
13 |
12 |
$0.45 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
13 |
13 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
12 |
12 |
$0.00 |
| J3490 |
Unclassified drugs |
12 |
12 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
13 |
12 |
$0.00 |